Literature DB >> 25044446

Oxidized HDL induces cytotoxic effects: implications for atherogenic mechanism.

Valliyil Sasidharan Soumyarani1, Narayani Jayakumari.   

Abstract

Atherosclerosis can be considered as an inflammatory disease and oxidized low-density lipoprotein (oxLDL) is a critical factor in atherogenesis. Although high-density lipoprotein (HDL) is generally an antiatherogenic lipoprotein, this property can be compromised by functional impairment mainly due to oxidative modification. As such, understanding the proatherogenic properties exerted by oxidized-HDL (oxHDL) becomes more important. This study was focused on examining the role of oxHDL as a proatherogenic agent, using oxLDL as a positive control. The comparative toxicity of oxHDL and oxLDL having same range of malondialdehyde, to monocytes was evaluated. After treatment, markers for oxidative stress, inflammation, and cytotoxicity were quantitated. The results showed that like oxLDL, oxHDL induced significant oxidative stress, cytotoxicity, and release of TNF -alpha and MMP-9 in monocytes/macrophages, but was less potent than oxLDL in promoting these proatherogenic effects. Further, the effects of oxHDL for the enhanced formation of MMP-9 were found to be mediated by NADPH oxidase/ROS-JNK/ERK pathway, as one mechanism.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  Cytotoxicity; MMP-9; NADPH-oxidase; Oxidized-HDL; Oxidized-LDL; ROS

Mesh:

Substances:

Year:  2014        PMID: 25044446     DOI: 10.1002/jbt.21588

Source DB:  PubMed          Journal:  J Biochem Mol Toxicol        ISSN: 1095-6670            Impact factor:   3.642


  8 in total

1.  Structure-function analysis of naturally occurring apolipoprotein A-I L144R, A164S and L178P mutants provides insight on their role on HDL levels and cardiovascular risk.

Authors:  Christina Gkolfinopoulou; Faye Soukou; Ioannis Dafnis; Tahsin F Kellici; Despina Sanoudou; Thomas Mavromoustakos; Efstratios Stratikos; Angeliki Chroni
Journal:  Cell Mol Life Sci       Date:  2020-07-14       Impact factor: 9.261

2.  Oxidized high density lipoprotein induces macrophage apoptosis via toll-like receptor 4-dependent CHOP pathway.

Authors:  Shutong Yao; Hua Tian; Li Zhao; Jinguo Li; Libo Yang; Feng Yue; Yanyan Li; Peng Jiao; Nana Yang; Yiwei Wang; Xiangjian Zhang; Shucun Qin
Journal:  J Lipid Res       Date:  2016-11-28       Impact factor: 5.922

3.  Effects of a lifestyle intervention on markers of cardiometabolic risk and oxidized lipoproteins among obese adolescents with prediabetes.

Authors:  Ana Rentería-Mexía; Sonia Vega-López; Micah L Olson; Pamela D Swan; Chong D Lee; Allison N Williams; Gabriel Q Shaibi
Journal:  Public Health Nutr       Date:  2018-12-27       Impact factor: 4.022

4.  Oxidized high-density lipoprotein promotes CD36 palmitoylation and increases lipid uptake in macrophages.

Authors:  Yun Zhang; Doudou Dong; Xiaoting Xu; Hui He; Yuan Zhu; Tingwen Lei; Hailong Ou
Journal:  J Biol Chem       Date:  2022-04-29       Impact factor: 5.486

5.  The influence of hypoxic physical activity on cfDNA as a new marker of vascular inflammation.

Authors:  Andrzej Pokrywka; Agnieszka Zembron-Lacny; Katarzyna Baldy-Chudzik; Joanna Orysiak; Dariusz Sitkowski; Maciej Banach
Journal:  Arch Med Sci       Date:  2015-12-11       Impact factor: 3.318

6.  Porphyromonas gingivalis accelerates atherosclerosis through oxidation of high-density lipoprotein.

Authors:  Hyun-Joo Kim; Gil Sun Cha; Hyung-Joon Kim; Eun-Young Kwon; Ju-Youn Lee; Jeomil Choi; Ji-Young Joo
Journal:  J Periodontal Implant Sci       Date:  2018-02-27       Impact factor: 2.614

Review 7.  Lipoproteins as targets and markers of lipoxidation.

Authors:  Catarina B Afonso; Corinne M Spickett
Journal:  Redox Biol       Date:  2018-12-06       Impact factor: 11.799

8.  Depletion of Lipid Efflux Pump ABCG1 Triggers the Intracellular Accumulation of Extracellular Vesicles and Reduces Aggregation and Tumorigenesis of Metastatic Cancer Cells.

Authors:  Yuri Namba; Chiharu Sogawa; Yuka Okusha; Hotaka Kawai; Mami Itagaki; Kisho Ono; Jun Murakami; Eriko Aoyama; Kazumi Ohyama; Jun-Ichi Asaumi; Masaharu Takigawa; Kuniaki Okamoto; Stuart K Calderwood; Ken-Ichi Kozaki; Takanori Eguchi
Journal:  Front Oncol       Date:  2018-10-10       Impact factor: 6.244

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.